Tumor necrosis factor-alpha-induced neutral sphingomyelinase-2 modulates synaptic plasticity by controlling the membrane insertion of NMDA receptors.
about
Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicitySimvastatin prevents dopaminergic neurodegeneration in experimental parkinsonian models: the association with anti-inflammatory responsesRoles and regulation of neutral sphingomyelinase-2 in cellular and pathological processesSphingolipids in spinal cord injuryAlterations of the Ceramide Metabolism in the Peri-Infarct Cortex Are Independent of the Sphingomyelinase Pathway and Not Influenced by the Acid Sphingomyelinase Inhibitor FluoxetineCambinol, a novel inhibitor of neutral sphingomyelinase 2 shows neuroprotective propertiesGrowth factors in synaptic function.Effects of C-phycocyanin and Spirulina on salicylate-induced tinnitus, expression of NMDA receptor and inflammatory genesExpression of tumor necrosis factor-α and interleukin-1β genes in the cochlea and inferior colliculus in salicylate-induced tinnitus.Inhibition of neutral sphingomyelinase-2 perturbs brain sphingolipid balance and spatial memory in mice.Sphingomyelin metabolism at the plasma membrane: implications for bioactive sphingolipids.Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidenceRoles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis.Plasma membrane sphingomyelin hydrolysis increases hippocampal neuron excitability by sphingosine-1-phosphate mediated mechanisms.In vivo composition of NMDA receptor signaling complexes differs between membrane subdomains and is modulated by PSD-95 and PSD-93Activation of TRPML1 clears intraneuronal Aβ in preclinical models of HIV infection.Neuropeptide Y protects cerebral cortical neurons by regulating microglial immune functionAnterograde and retrograde transport of neutral sphingomyelinase-2 between the Golgi and the plasma membrane.Blockade of lysosomal acid ceramidase induces GluN2B-dependent Tau phosphorylation in rat hippocampal slices.Intrathecal injection of spironolactone attenuates radicular pain by inhibition of spinal microglia activation in a rat modelTNF-α and Microglial Hormetic Involvement in Neurological Health & MigraineCerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics.Age-dependent changes in the sphingolipid composition of mouse CD4+ T cell membranes and immune synapses implicate glucosylceramides in age-related T cell dysfunctionNeuroprotective effect of lovastatin by inhibiting NMDA receptor1 in 6-hydroxydopamine treated PC12 cellsSpinal cord injury causes chronic liver pathology in rats.Spreading depression transiently disrupts myelin via interferon-gamma signaling.Endoplasmic reticulum Ca(2+) handling in excitable cells in health and diseasePeripherally restricted acute phase response to a viral mimic alters hippocampal gene expression.Disturbance in cerebral spinal fluid sphingolipid content is associated with memory impairment in subjects infected with the human immunodeficiency virusCeramide metabolism analysis in a model of binge drinking reveals both neuroprotective and toxic effects of ethanol.Increased levels of HMGB1 and pro-inflammatory cytokines in children with febrile seizures.Lipid rafts and Alzheimer's disease: protein-lipid interactions and perturbation of signaling.Early intervention with a small molecule inhibitor for tumor necrosis factor-α prevents cognitive deficits in a triple transgenic mouse model of Alzheimer's diseaseDendritic spine injury induced by the 8-hydroxy metabolite of efavirenz.Immune-neural connections: how the immune system's response to infectious agents influences behaviorCytokines and brain excitability.Transgenic mice with increased astrocyte expression of IL-6 show altered effects of acute ethanol on synaptic function.HIV-1 Tat-Mediated Calcium Dysregulation and Neuronal Dysfunction in Vulnerable Brain Regions.Genetics of Lipid-Storage Management in Caenorhabditis elegans EmbryosFatty acid synthase causes drug resistance by inhibiting TNF-α and ceramide production
P2860
Q21284512-08C99609-7E13-4F44-B238-C0951B47A80DQ21560808-7783FEE8-2F76-444F-A5AF-D27A51FA927BQ27022944-D2A313F5-C85E-4842-9B3D-FE0DB6D0E13DQ27026103-7E508C55-BE1C-4ED8-AD3B-909A1927EA5DQ28270227-4AC72EEA-5650-4445-87F2-B72E88CD62F8Q28547451-72CAB0DF-6B0D-4A9B-A09B-514BF07A3C97Q30449007-4D9021BD-B088-4216-AE97-4F3B1316C922Q30456064-E397DCC9-7E0C-471F-9B09-9EA16E098E1CQ30475567-7ACC7330-6A71-44AF-BCC9-1B8B5B0E0CD7Q30495972-D7AE9453-4029-46B6-8309-3F2E08BCDE3EQ33798777-79D16F0A-246C-4B15-BA9F-78251C4108D0Q33947639-6706293B-AE34-481A-92F0-208B8C66F3C0Q34007818-E10E8B80-1EE3-4DCB-9636-F6F1F23DD3F5Q34020587-524C500F-83B1-4B8C-AA31-446809E642EDQ34029974-42E0821B-2551-4F77-B3EB-9E74B9435E4DQ34067393-B31FDDA8-2958-4C5A-BBFE-AB0D2D279BB8Q34095937-F25038B0-4307-435D-95B7-0F6A4EBA08F0Q34213317-CF7B60D6-639B-41F4-98C8-A641C22E59A6Q34223486-5D168D73-079B-47A3-A5C3-E5440EC3CB02Q34328380-79E6A134-1DEE-4E3E-92D1-BE8F1A8FA9FDQ34341918-A87E1F66-9CA8-4FA9-B9A2-F274A9E4F26DQ34422726-0427493B-4337-4068-A58D-978F52258A7BQ34460494-649AAF83-115D-41D0-B586-E8ABE2144408Q34547840-CE118E56-F135-4E37-980C-2527AD20C184Q34983871-B0D14E10-69F4-4DBB-BA00-FEB6E31429D4Q35071478-6F3FE428-0228-45D5-A249-F823E0F80040Q35122788-00241711-ABE6-4337-98C6-EEDAF0753D31Q35128609-06362E3E-6361-4800-96F6-12971FA48058Q35130214-C5E13A91-C29C-492B-9A2F-E07A99AE438BQ35519881-79ACB631-5BF2-417C-97AF-DAF35DE77E60Q35533529-FB4BB6C4-EAD9-4A77-8750-0FDC9158266FQ36052691-7D77D561-7680-4ACE-942D-6BFF140E0A4EQ36112435-F8802530-EC4C-4678-ADF5-BA2639B401E9Q36406259-1867642F-AC4D-499D-93F7-F4DB8E458AA4Q36447409-6E1BCC5D-698A-4D27-B56C-A775C54AD684Q36542185-DAF55542-A08E-4E0B-9C37-B74EAF2A6755Q36586181-60197734-B630-4AA9-BC94-D28714491269Q36634476-DAE2D376-BC93-4A6D-A3B2-074C1E02B0EDQ36677071-B5331708-2CC7-4AAA-9781-DB2BC3912D4FQ36744130-C4AAF211-BB7B-47C0-B44B-C686B9DE66AF
P2860
Tumor necrosis factor-alpha-induced neutral sphingomyelinase-2 modulates synaptic plasticity by controlling the membrane insertion of NMDA receptors.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Tumor necrosis factor-alpha-in ...... e insertion of NMDA receptors.
@ast
Tumor necrosis factor-alpha-in ...... e insertion of NMDA receptors.
@en
type
label
Tumor necrosis factor-alpha-in ...... e insertion of NMDA receptors.
@ast
Tumor necrosis factor-alpha-in ...... e insertion of NMDA receptors.
@en
prefLabel
Tumor necrosis factor-alpha-in ...... e insertion of NMDA receptors.
@ast
Tumor necrosis factor-alpha-in ...... e insertion of NMDA receptors.
@en
P2093
P2860
P1476
Tumor necrosis factor-alpha-in ...... e insertion of NMDA receptors.
@en
P2093
Christophe Poirier
David Knorr
David Wheeler
Edward Knapp
Jonathan D Geiger
Norman J Haughey
Veera V R Bandaru
P2860
P304
P356
10.1111/J.1471-4159.2009.06038.X
P407
P50
P577
2009-03-14T00:00:00Z